Research Article
Epicatechin Used in the Treatment of Intestinal Inflammatory Disease: An Analysis by Experimental Models
Table 4
Macroscopic and microscopic scores of the colitic lesions of different groups submitted to the chronic colitis model with relapse.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Results expressed as median (interquartile range). Kruskal-Wallis-Mann-Whitney, *P < 0.05 comparing to TNBS group, #P < 0.05 comparing to not relapsed TNBS control. n = 4–7. EC 10 and 50: Epicatechin, dose 10 and 50 mg/kg. |